Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 88

1.

Moving Forward: Recent Developments for the Ferret Biomedical Research Model.

Albrecht RA, Liu WC, Sant AJ, Tompkins SM, Pekosz A, Meliopoulos V, Cherry S, Thomas PG, Schultz-Cherry S.

MBio. 2018 Jul 17;9(4). pii: e01113-18. doi: 10.1128/mBio.01113-18. Review.

2.

Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge.

Nachbagauer R, Shore D, Yang H, Johnson SK, Gabbard JD, Tompkins SM, Wrammert J, Wilson PC, Stevens J, Ahmed R, Krammer F, Ellebedy AH.

J Virol. 2018 Jul 31;92(16). pii: e00949-18. doi: 10.1128/JVI.00949-18. Print 2018 Aug 15.

3.

Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses.

Yoon JJ, Toots M, Lee S, Lee ME, Ludeke B, Luczo JM, Ganti K, Cox RM, Sticher ZM, Edpuganti V, Mitchell DG, Lockwood MA, Kolykhalov AA, Greninger AL, Moore ML, Painter GR, Lowen AC, Tompkins SM, Fearns R, Natchus MG, Plemper RK.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00766-18. doi: 10.1128/AAC.00766-18. Print 2018 Aug.

4.

Developing a platform system for gene delivery: amplifying virus-like particles (AVLP) as an influenza vaccine.

Wei H, Chen Z, Elson A, Li Z, Abraham M, Phan S, Kristhnamurthy S, McCray PB Jr, Andrews S, Stice S, Sakamoto K, Jones C, Tompkins SM, He B.

NPJ Vaccines. 2017 Nov 20;2:32. doi: 10.1038/s41541-017-0031-7. eCollection 2017.

5.

Influenza Pathogenesis in Genetically Defined Resistant and Susceptible Murine Strains

.

Samet SJ, Tompkins SM.

Yale J Biol Med. 2017 Sep 25;90(3):471-479. eCollection 2017 Sep. Review.

6.

Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.

Mooney AJ, Gabbard JD, Li Z, Dlugolenski DA, Johnson SK, Tripp RA, He B, Tompkins SM.

J Virol. 2017 Nov 14;91(23). pii: e01579-17. doi: 10.1128/JVI.01579-17. Print 2017 Dec 1.

7.

Potential for Low-Pathogenic Avian H7 Influenza A Viruses To Replicate and Cause Disease in a Mammalian Model.

Zanin M, Koçer ZA, Poulson RL, Gabbard JD, Howerth EW, Jones CA, Friedman K, Seiler J, Danner A, Kercher L, McBride R, Paulson JC, Wentworth DE, Krauss S, Tompkins SM, Stallknecht DE, Webster RG.

J Virol. 2017 Jan 18;91(3). pii: e01934-16. doi: 10.1128/JVI.01934-16. Print 2017 Feb 1.

8.

Comparison of Microchip Transponder and Noncontact Infrared Thermometry with Rectal Thermometry in Domestic Swine (Sus scrofa domestica).

Jara AL, Hanson JM, Gabbard JD, Johnson SK, Register ET, He B, Tompkins SM.

J Am Assoc Lab Anim Sci. 2016;55(5):588-93.

9.

Coated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunity.

Wang L, Chang TZ, He Y, Kim JR, Wang S, Mohan T, Berman Z, Tompkins SM, Tripp RA, Compans RW, Champion JA, Wang BZ.

Nanomedicine. 2017 Jan;13(1):253-262. doi: 10.1016/j.nano.2016.09.001. Epub 2016 Sep 10.

10.

Environmental Stability of Swine and Human Pandemic Influenza Viruses in Water under Variable Conditions of Temperature, Salinity, and pH.

Poulson RL, Tompkins SM, Berghaus RD, Brown JD, Stallknecht DE.

Appl Environ Microbiol. 2016 Jun 13;82(13):3721-3726. doi: 10.1128/AEM.00133-16. Print 2016 Jul 1.

11.

Erratum to: Serial passage in ducks of a low-pathogenic avian influenza virus isolated from a chicken reveals a high mutation rate in the hemagglutinin that is likely due to selection in the host.

Ridenour C, Williams SM, Jones L, Tompkins SM, Tripp RA, Mundt E.

Arch Virol. 2016 May;161(5):1423. doi: 10.1007/s00705-016-2837-4. No abstract available.

PMID:
27038824
12.

Genome-wide siRNA Screening at Biosafety Level 4 Reveals a Crucial Role for Fibrillarin in Henipavirus Infection.

Deffrasnes C, Marsh GA, Foo CH, Rootes CL, Gould CM, Grusovin J, Monaghan P, Lo MK, Tompkins SM, Adams TE, Lowenthal JW, Simpson KJ, Stewart CR, Bean AG, Wang LF.

PLoS Pathog. 2016 Mar 24;12(3):e1005478. doi: 10.1371/journal.ppat.1005478. eCollection 2016 Mar.

13.

Engineering Enhanced Vaccine Cell Lines To Eradicate Vaccine-Preventable Diseases: the Polio End Game.

van der Sanden SM, Wu W, Dybdahl-Sissoko N, Weldon WC, Brooks P, O'Donnell J, Jones LP, Brown C, Tompkins SM, Oberste MS, Karpilow J, Tripp RA.

J Virol. 2015 Nov 18;90(4):1694-704. doi: 10.1128/JVI.01464-15. Print 2016 Feb 15.

14.

Detection of neuraminidase stalk motifs associated with enhanced N1 subtype influenza A virulence via Raman spectroscopy.

Choi J, Martin SJ, Tripp RA, Tompkins SM, Dluhy RA.

Analyst. 2015 Nov 21;140(22):7748-60. doi: 10.1039/c5an00977d.

15.

Serial passage in ducks of a low-pathogenic avian influenza virus isolated from a chicken reveals a high mutation rate in the hemagglutinin that is likely due to selection in the host.

Ridenour C, Williams SM, Jones L, Tompkins SM, Tripp RA, Mundt E.

Arch Virol. 2015 Oct;160(10):2455-70. doi: 10.1007/s00705-015-2504-1. Epub 2015 Jul 16. Erratum in: Arch Virol. 2016 May;161(5):1423.

PMID:
26179620
16.

Efficacy of a parainfluenza virus 5 (PIV5)-based H7N9 vaccine in mice and guinea pigs: antibody titer towards HA was not a good indicator for protection.

Li Z, Gabbard JD, Johnson S, Dlugolenski D, Phan S, Tompkins SM, He B.

PLoS One. 2015 Mar 24;10(3):e0120355. doi: 10.1371/journal.pone.0120355. eCollection 2015.

17.

Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 Expression.

Dlugolenski D, Jones L, Howerth E, Wentworth D, Tompkins SM, Tripp RA.

J Virol. 2015 May;89(10):5651-67. doi: 10.1128/JVI.00087-15. Epub 2015 Mar 11.

18.

Interferon Lambda Upregulates IDO1 Expression in Respiratory Epithelial Cells After Influenza Virus Infection.

Fox JM, Crabtree JM, Sage LK, Tompkins SM, Tripp RA.

J Interferon Cytokine Res. 2015 Jul;35(7):554-62. doi: 10.1089/jir.2014.0052. Epub 2015 Mar 10.

19.

Memory T cells generated by prior exposure to influenza cross react with the novel H7N9 influenza virus and confer protective heterosubtypic immunity.

McMaster SR, Gabbard JD, Koutsonanos DG, Compans RW, Tripp RA, Tompkins SM, Kohlmeier JE.

PLoS One. 2015 Feb 11;10(2):e0115725. doi: 10.1371/journal.pone.0115725. eCollection 2015.

20.

In ovo and in vitro susceptibility of American alligators (Alligator mississippiensis) to avian influenza virus infection.

Temple BL, Finger JW Jr, Jones CA, Gabbard JD, Jelesijevic T, Uhl EW, Hogan RJ, Glenn TC, Tompkins SM.

J Wildl Dis. 2015 Jan;51(1):187-98. doi: 10.7589/2013-12-321.

PMID:
25380354

Supplemental Content

Loading ...
Support Center